Ipsen-RFP-Rare-2026-02
Ipsen-RFP-Rare-2026-02 supports independent education for clinicians on individualized treatment and symptom assessment in primary biliary cholangitis to improve clinical decision-making.
Funder: Ipsen
Due Dates: October 1, 2026 (submission deadline)
Funding Amounts: Up to $300,000; enduring component active for at least 12 months
Summary: Supports independent medical education on individualized treatment and symptom assessment in primary biliary cholangitis.
Key Information: Programs must include live education at a U.S. national congress and subsequent enduring content.
Description
Ipsen seeks proposals for independent medical education addressing unmet needs in primary biliary cholangitis (PBC). This request focuses on integrating biochemical markers and symptom assessment into individualized therapeutic strategies. Ipsen is looking for multiple proposals across 2026–2027 national congresses that reach advanced practice providers, gastroenterologists, and hepatologists.
Programs should address treatment optimization, including alkaline phosphatase normalization where appropriate; translate emerging evidence into clinical decisions; and improve routine assessment and management of symptoms such as fatigue and pruritus, independently of biochemical response. Applicants are responsible for designing and conducting their programs without Ipsen’s involvement in educational content.
